Real Life Efficacy And Tolerability Of Tenofovir Alafenamide Fumarate In Patients With Hepatitis B Virus-Related Cirrhosis And Liver Transplant Recipients. A-Preliminary Result
dc.contributor.author | Etik, Digdem Ozer | |
dc.contributor.author | Boyacioglu, Sedat | |
dc.date.accessioned | 2022-08-02T08:19:09Z | |
dc.date.available | 2022-08-02T08:19:09Z | |
dc.date.issued | 2021 | |
dc.identifier.endpage | 490A | en_US |
dc.identifier.issn | 0270-9139 | en_US |
dc.identifier.issue | Supplement 1 | en_US |
dc.identifier.startpage | 490A | en_US |
dc.identifier.uri | http://hdl.handle.net/11727/7184 | |
dc.identifier.volume | 74 | en_US |
dc.identifier.wos | 000707188002208 | en_US |
dc.language.iso | eng | en_US |
dc.relation.journal | HEPATOLOGY | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.title | Real Life Efficacy And Tolerability Of Tenofovir Alafenamide Fumarate In Patients With Hepatitis B Virus-Related Cirrhosis And Liver Transplant Recipients. A-Preliminary Result | en_US |
dc.type | conferenceObject | en_US |
Files
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: